Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...

In its purest form, product-led GTM lets the product speak for itself. By reducing or even eliminating the roles of sales, marketing and advertising, it looks like an obvious cost-saver. Of course, it ...

Seer will host a conference call to discuss the third quarter 2024 financial results on Wednesday, November 6, 2024 at 1:30 pm Pacific Time / 4:30 pm Eastern Time. A webcast of the conference call can ...

Streamlining Microbial Quality Control with MicroQuant™ In the ever-evolving landscape of pharmaceutical testing, ensuring ...

Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...